| Name | Title | Contact Details |
|---|
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.
National Surgical Adjuvant Breast & Bowel is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sarah Cannon Research Institute is a research organization focusing on therapies for patients including drug development.
Qbc Diagnostics Inc is a State College, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avantis Medical Systems Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Sunnyvale, CA. To find more information about Avantis Medical Systems Inc., please visit www.avantismedical.com